Topical Peptides is a recurring topic in our peptide coverage. This hub collects every article tagged Topical Peptides, newest first, each evidence-graded and tied to real, verifiable sources.
A clinical look at copper peptides (GHK-Cu) and Matrixyl for striae distensae. No dedicated human trial exists for either — both grade D for stretch marks specifically, despite stronger data on other skin.
A master, evidence-graded overview of the aesthetic peptide field — GHK-Cu, Matrixyl, Argireline, Synthe'6 and the neuromodulator cast — separating small topical human RCTs from in-vitro mechanism and marketing. The honest ceiling is Grade B.
Which cosmetic peptides actually soften wrinkles and photoaging — GHK-Cu, Matrixyl, argireline and more — ranked honestly by the human evidence. All are Grade B: modest, topical, delivery-limited, none Grade A.
An evidence-graded ranking of the peptides marketed for hair thinning, density, and shedding — separating the modest human topical data from the mechanistic and mouse-only hype.
An evidence-graded ranking of the peptides marketed for androgenetic alopecia — zinc-thymulin, biotinoyl tripeptide-1/Procapil, GHK-Cu copper peptide, and PTD-DBM — separating the small human data from mouse work, blends, and marketing.
An evidence-graded ranking of the topical matrikine and copper peptides marketed for collagen, elastin and firmness — GHK-Cu, Matrixyl, palmitoyl tripeptide-1 and Synthe'6 — separating small human RCTs from in-vitro mechanism and marketing.
An evidence-graded ranking of the peptides marketed for cellulite — oral collagen peptides, GHK-Cu, AOD-9604 and HGH Fragment 176-191 — separating the one modest human signal from mechanism, marketing and WADA-banned research chemicals.
An evidence-graded ranking of the peptides studied for atrophic acne scarring — copper tripeptide, the TriHex matrikine blend, and Matrixyl — separating the small human adjunct data from in-vitro mechanism and marketing.
A clinical monograph on SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate, Tripeptide-3) — the snake-venom-mimetic 'Botox-in-a-jar' topical peptide. Strong in-vitro receptor data, modest sponsor-run human data, and no independent RCT of the isolated peptide.
A clinical monograph on Pentapeptide-18 (Leuphasyl) — the enkephalin-derived, presynaptic cosmetic peptide marketed alongside the SNAP-25-mimetic Argireline. One small human study, manufacturer synergy data, and a poor-delivery caveat.
A clinical monograph on Palmitoyl Tripeptide-1 (pal-GHK) — the lipid-anchored GHK matrikine and half of Matrixyl 3000. Small vehicle-controlled topical trials, strong in-vitro mechanism, and a settled cosmetic legal status.
A clinical monograph on Matrixyl (palmitoyl pentapeptide-4, Pal-KTTKS) — the topical anti-aging cosmetic peptide. One positive industry RCT, one null independent RCT, consistent in-vitro collagen data, and a clean cosmetic safety record.
A clinical monograph on palmitoyl tripeptide-38 (Matrixyl Synthe'6) — the topical matrikine marketed to rebuild six matrix proteins. Real but low-tier, manufacturer-led human data, no independent RCT.
A clinical monograph on Biotinoyl Tripeptide-1 — the biotinylated GHK matrikine peptide behind Procapil. Modest, consistent hair-density benefits in combination formulations, but no isolated-molecule human trial.
A clinical monograph on Argireline — the 'topical Botox' peptide. Modest human evidence (Grade B), a real SNAP-25 mechanism, and a delivery problem that undercuts the marketing.
Topical Peptides is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.
This hub updates automatically whenever a new article is tagged Topical Peptides, so the latest coverage appears first.
Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.